Group 1 - Multiple fund companies have submitted applications for science and technology bond index funds, with 12 companies applying this year as of May 27 [1] - Bosera Fund announced a self-purchase of floating rate funds, investing 10 million yuan each in two newly launched equity funds, reflecting confidence in the long-term stability of China's capital market [2] - Several North China 50 index funds have implemented purchase limits to protect the interests of existing fund holders, with varying daily purchase limits set by different funds [3][4] Group 2 - Fund companies have been actively increasing new share classes for their products, with C, D, and E share classes being introduced in May [5] - Cai Leping has been appointed as the general manager of the index and quantitative investment department at Yongying Fund, bringing 8 years of experience in the securities industry [6] - Fund managers are optimistic about investment opportunities in the innovative pharmaceutical sector, predicting a significant growth phase in 2025 for the industry [7][8] Group 3 - The stock market experienced a rebound on May 29, with major indices showing gains and a notable increase in trading volume, particularly in sectors like computer equipment and biotechnology [9]